A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study

被引：0
作者：
Xin Tang
Yuan Li
Wen-lei Qian
Wei-feng Yan
Tong Pang
You-ling Gong
Zhi-gang Yang
机构：
[1] West China Hospital,Department of Radiology
[2] Sichuan University,Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer Center
[3] West China Hospital,undefined
[4] Sichuan University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Osimertinib; EGFR-T790M; Non-small cell lung cancer; Prognostic analysis; Real-world study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2475 / 2486
页数：11
相关论文
共 429 条
[31]  
Box M(2019)Clinical characteristics of osimertinib responder in non-small cell lung cancer patients with EGFR-T790M mutation Cancers (basel) 11 2240-undefined
[32]  
Johnström P(2013)Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers Clin Cancer Res 19 17-undefined
[33]  
Varnäs K(2014)Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysis PLoS ONE 9 undefined-undefined
[34]  
Malmquist J(2020)EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients Clin Transl Med 9 undefined-undefined
[35]  
Thress KS(undefined)undefined undefined undefined undefined-undefined
[36]  
Jänne PA(undefined)undefined undefined undefined undefined-undefined
[37]  
Cross D(undefined)undefined undefined undefined undefined-undefined
[38]  
Campo M(undefined)undefined undefined undefined undefined-undefined
[39]  
Gerber D(undefined)undefined undefined undefined undefined-undefined
[40]  
Gainor JF(undefined)undefined undefined undefined undefined-undefined
12345678910